• EAU Update on Prostate Cancer

PCa20 in Madrid has been cancelled

Unfortunately, the 4th EAU Update on Prostate Cancer in Madrid is cancelled in light of the ongoing COVID-19 pandemic. The health of all participants and faculty is of course the highest priority. PCa20 was scheduled to take place 12-13 September but the scientific committee has decided to explore online options for 2020 and reschedule the meeting for 2021. New dates will be announced shortly. All participants have been contacted by e-mail about their registrations.

PCa20: New Developments, New Perspectives

Insight and skilled decision-making are crucial in prostate cancer (PCa) diagnosis and treatment. The 4th EAU Update on Prostate Cancer, to be held from 12-13 September in Madrid, Spain, addresses this challenge with an expert-led meeting that is both comprehensive and compact.

Unique with its fully interactive format, prostate cancer experts from across Europe will challenge participants with a critical assessment of standard and the latest prospective PCa therapies. In collaboration with the European School of Urology (ESU), the two-day programme will examine key topics in optimal PCa management.

From insightful overviews to point-by-point assessment of treatment strategies, expert lecturers will take participants through a range of issues on current guidelines, clinical dilemmas, and medical management. Stock knowledge will be tested against the impact of new drug research and evolving use of imaging technologies. With incisive, to-the-point commentary, the faculty will tackle systemic treatments, metastatic disease, drug sequencing and complications management.

Pre- and post-meeting testing will be required for a thorough assessment of the participants’ PCa knowledge. While emphasising evidence-based medicine, interactive breakout sessions will explore difficulties in diagnosis, the use of imaging tools, and effective follow-up strategies. Case discussions and topic-focused sessions led by a rotating faculty will aim for in-depth inquiry into contentious issues such as local salvage therapy, active surveillance and managing recurrent disease.

PCa20, as part of the onco-urology educational series organised by the EAU, is an opportunity in continuing medication education that responds to cancer and healthcare professionals looking for a practical, comprehensive and incisive update.

Join us in Madrid!

Morgan Roupret Arnulf Stenzl
Prof. Morgan Rouprêt
PCa20 Steering committee
Prof. Dr. Arnulf Stenzl
PCa20 Steering committee


Share the EAU Update on Prostate Cancer Meeting 2020 with your friends and colleagues:


Top-3 reasons to visit PCa20

In-depth, expert-led discussions


Expert specialists will focus on clinical dilemmas and steer the sessions for an in-depth discussion on controversial topics.

Insights on management strategies


From guideline recommendations to insights on new research outcomes, PCa20 identifies key issues in PCa management, boosting your knowledge on novel treatment approaches.

Interactive and unique


Comprehensive and compact updates will precede breakout sessions. Best practices in surgery and optimal medical treatments are carefully examined in this unique educational event.